The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of systemic chemotherapy with or without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger study).
 
Masanori Tokunaga
No Relationships to Disclose
 
Nozomu Machida
Honoraria - Chugai Pharma; Lilly; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Taiho Pharmaceutical (Inst)
 
Junki Mizusawa
Speakers' Bureau - Chugai Pharma
 
Hiroshi Katayama
No Relationships to Disclose
 
Hiroya Taniguchi
Honoraria - Chugai Pharma; Merck Serono; Otsuka; Taiho Pharmaceutical; Takeda
Research Funding - Boehringer Ingelheim (Inst); MSD (Inst); Otsuka (Inst)
 
Kohei Shitara
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Novartis; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Toshihiko Tomita
No Relationships to Disclose
 
Takaki Yoshikawa
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Takeshi Sano
No Relationships to Disclose
 
Mitsuru Sasako
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Masanori Terashima
No Relationships to Disclose